Scarica l'app Stockscreener
12.79
0.39%
-0.05
Precedente Chiudi:
$12.84
Aprire:
$12.9
Volume 24 ore:
875.56K
Relative Volume:
0.59
Capitalizzazione di mercato:
$712.15M
Reddito:
$312.78M
Utile/perdita netta:
$-143.56M
Rapporto P/E:
-4.7546
EPS:
-2.69
Flusso di cassa netto:
$1.22M
1 W Prestazione:
+7.34%
1M Prestazione:
-33.07%
6M Prestazione:
-42.75%
1 anno Prestazione:
-32.22%
Intervallo 1D:
$12.70
$13.07
Intervallo di 1 settimana:
$11.62
$13.35
Portata 52W:
$10.96
$34.84
Caredx Inc Stock (CDNA) Company Profile
Nome
Caredx Inc
Settore
Industria
Telefono
415-287-2300
Indirizzo
8000 MARINA BLVD, BRISBANE, CA
Confronta CDNA con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CDNA
Caredx Inc
|
12.79 | 714.94M | 312.78M | -143.56M | 1.22M | -2.69 |
|
TMO
Thermo Fisher Scientific Inc
|
478.32 | 179.32B | 43.21B | 6.58B | 6.17B | 17.29 |
|
DHR
Danaher Corp
|
205.48 | 145.22B | 24.01B | 3.41B | 4.86B | 4.70 |
|
IDXX
Idexx Laboratories Inc
|
565.19 | 44.23B | 3.93B | 894.97M | 837.70M | 10.82 |
|
IQV
Iqvia Holdings Inc
|
199.17 | 34.14B | 15.50B | 1.33B | 2.16B | 7.34 |
|
A
Agilent Technologies Inc
|
120.18 | 34.19B | 6.63B | 1.17B | 1.19B | 4.05 |
Caredx Inc Stock (CDNA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-01-15 | Aggiornamento | Wells Fargo | Underweight → Equal Weight |
| 2024-08-28 | Iniziato | Wells Fargo | Underweight |
| 2024-08-19 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2024-05-13 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2024-05-01 | Aggiornamento | Craig Hallum | Hold → Buy |
| 2023-11-09 | Aggiornamento | Stephens | Equal-Weight → Overweight |
| 2023-08-15 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2023-05-11 | Downgrade | BTIG Research | Buy → Neutral |
| 2023-03-07 | Downgrade | Stephens | Overweight → Equal-Weight |
| 2023-03-03 | Downgrade | Craig Hallum | Buy → Hold |
| 2023-03-03 | Downgrade | Raymond James | Strong Buy → Mkt Perform |
| 2022-04-25 | Iniziato | Stephens | Overweight |
| 2021-07-20 | Ripresa | BTIG Research | Buy |
| 2021-06-03 | Iniziato | Goldman | Buy |
| 2021-02-26 | Downgrade | H.C. Wainwright | Buy → Neutral |
| 2020-10-30 | Reiterato | H.C. Wainwright | Buy |
| 2020-10-08 | Reiterato | H.C. Wainwright | Buy |
| 2020-10-02 | Reiterato | H.C. Wainwright | Buy |
| 2020-08-05 | Reiterato | H.C. Wainwright | Buy |
| 2020-06-26 | Iniziato | BTIG Research | Buy |
| 2020-06-19 | Reiterato | H.C. Wainwright | Buy |
| 2019-10-01 | Ripresa | Craig Hallum | Buy |
| 2019-05-09 | Aggiornamento | H.C. Wainwright | Neutral → Buy |
| 2019-02-15 | Iniziato | Jefferies | Buy |
| 2018-10-23 | Ripresa | Raymond James | Strong Buy |
| 2018-09-18 | Reiterato | H.C. Wainwright | Neutral |
| 2017-11-27 | Iniziato | H.C. Wainwright | Buy |
| 2016-06-14 | Reiterato | Mizuho | Buy |
| 2015-09-29 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2015-09-25 | Iniziato | Craig Hallum | Buy |
| 2015-03-18 | Reiterato | Mizuho | Buy |
Mostra tutto
Caredx Inc Borsa (CDNA) Ultime notizie
Will CareDx Inc stock benefit from AI tech trendsFree Investment Community - jammulinksnews.com
What drives CareDx Inc stock priceGame-changing returns - Autocar Professional
CareDx rebounds as draft LCD suggests no change in coverage - MSN
CareDx Settlement Approved — Here’s How to Get Your Share - TradingView
The Market Doesn't Like What It Sees From CareDx, Inc's (NASDAQ:CDNA) Revenues Yet As Shares Tumble 32% - simplywall.st
CareDx To Report Second Quarter 2025 Financial Results - Barchart.com
ADF GROUP INC. ANNOUNCES THE SIGNING OF A MAJOR LONG-TERM CONTRACT IN QUEBEC'S ENERGY SECTOR, WHICH AT MATURITY, COULD TOTAL CLOSE TO $400 MILLION - The Globe and Mail
What analysts say about CareDx Inc stockPhenomenal capital gains - jammulinksnews.com
Is CareDx Inc a good long term investmentHigh-impact stock picks - jammulinksnews.com
CareDx Inc Stock Analysis and ForecastPowerful profit generation - jammulinksnews.com
CareDx (NASDAQ:CDNA shareholders incur further losses as stock declines 33% this week, taking five-year losses to 60% - Yahoo Finance
CareDx (CDNA) Surges 7.0%: Is This an Indication of Further Gains? - Yahoo Finance
How to Take Advantage of moves in (CDNA) - news.stocktradersdaily.com
Buying the Dips in 2 Diagnostic Names After 'Significant Overreactions' - TheStreet Pro
CareDx's Strategic Positioning in the Evolving Transplant Diagnostics Market: Reinforcing Revenue Stability and Long-Term Growth - AInvest
CareDx Rebounds After Draft LCD Suggests No Change in Coverage - AInvest
CareDx (CDNA): Analyst Rating Maintained, Price Target Lowered | - GuruFocus
CareDx Announces Proposed Draft LCD That Affirms Surveillance Testing Coverage for Solid Organ Transplant Rejection - Business Wire
CareDx Announces Proposed Draft LCD That Affirms Surveillance Testing Coverage for Solid Organ Transplant Rejection | Site verification - FinancialContent
Caredx Inc stock hits 52-week low at 14.07 USD By Investing.com - Investing.com Nigeria
Caredx Inc stock hits 52-week low at 14.07 USD - Investing.com
CareDx Plummets 38% Intraday: What's Behind the Record Collapse? - AInvest
Why CareDx Inc stock attracts strong analyst attentionExpert Trading Flow - Newser
How CareDx Inc stock performs during market volatilityTargeted 200 Percent Gain - Newser
What makes CareDx Inc stock price move sharplyFast Moving Stock Alerts - Newser
CareDx Q2 2024 presentation: Revenue jumps 31%, company raises full-year guidance - Investing.com Australia
CareDx Q2 2024 presentation: Revenue jumps 31%, company raises full-year guidance By Investing.com - Investing.com South Africa
Learn to Evaluate (CDNA) using the Charts - news.stocktradersdaily.com
Strong week for CareDx (NASDAQ:CDNA) shareholders doesn't alleviate pain of five-year loss - simplywall.st
Trilogy Metals Reports Second Quarter Fiscal 2025 Financial Results and Provides Updated Cash Position - The Globe and Mail
CareDx (CDNA) Stock Upgraded to Buy by Nephron Research | CDNA S - GuruFocus
CareDx’s HeartCare Study: A Game Changer in Transplant Monitoring? - The Globe and Mail
CareDx’s ALAMO Study: A Game Changer in Lung Transplant Surveillance? - TipRanks
CareDx’s ALAMO Study: A New Era in Lung Transplant Surveillance - TipRanks
CareDx ($CDNA) Is Paying a $20.25M Settlement to Investors — Here’s How to Get Your Share - TradingView
Rhumbline Advisers Trims Stock Position in CareDx, Inc. (NASDAQ:CDNA) - Defense World
Caredx Inc Azioni (CDNA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.50%
1.95%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):